Table 1

Main trial outcomes and intervention

IndiaMozambiquePakistan
Intervention
n=6908
Control
n=6109
Intervention
n=6941
Control
n=6239
Intervention
n=18 441
Control
n=17 350
Trial outcomes
Composite maternal and perinatal outcome (%)1252 (18.1)1157 (18.9)1246 (18)1172 (18.8)5373 (29.1)4187 (24.1)
Maternal mortality (%)7 (0.1)9 (0.1)15 (0.2)7 (0.1)55 (0.3)51 (0.3)
Maternal morbidity (%)371 (5.4)325 (5.3)735 (10.6)690 (11.1)2213 (12)1728 (10.0)
Stillbirth (%)191 (2.8)156 (2.6)196 (2.8)162 (2.6)935 (5.1)951 (5.5)
Neonatal death (%)179 (2.6%)136 (2.2)218 (3.1)171 (2.7)1011 (5.5)962 (5.5)
Neonatal morbidity (%)813 (11.8)790 (12.9)275 (4.0)362 (5.8)2375 (12.9)1684 (9.7)
Intervention
Community engagement sessions1379 groups4243 groups1379 groups1368 groups
16 691 CHW led
CHWs trained14879223
POM-guided contacts (n)57 56226 14554 782
POM-guided contacts per pregnancy8.0 (3.0, 12.0)4.0 (2.0, 6.0)3.0 (2.0, 5.0)
 0770
(11.1%)
2796 (40.3%)7905
(42.9%)
 1–31268 (18.3%)936
(13.5%)
2718 (14.7%)
 4–71363 (19.7%)1818 (26.2%)6008 (32.5%)
 ≥83507 (50.8%)1391 (20.0%)1810 (9.8%)
Pregnancies given methyldopa (%)60 (1.0)28 (0.7)93 (0.9)
 Accepted (%)51 (85.0)19 (67.9)92 (98.9)
Pregnancies given MgSO4 (%)67 (1.1)28 (0.7)103 (1.0)
 Accepted (%)47 (70.5)13 (46.4)73 (70.9)
Pregnancies referred to facility (%)505 (8.2)263 (6.3)487 (4.6)
 Accepted (%)401 (86.7)158 (68.4)305 (83.6)
  • CHW, community healthcare worker; MgSO4, magnesium sulfate; POM, PIERS (Pre-eclampsia Integrated Estimate of RiSk) On the Move.